NCT02882737View on ClinicalTrials.gov

The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Glucagon before exercise

DRUG

Glucagon after exercise

DRUG

Glucagon after resting

Trial Locations (1)

2650

Isabelle Steineck, Hvidovre

All Listed Sponsors
collaborator

Technical University of Denmark

OTHER

lead

Hvidovre University Hospital

OTHER

NCT02882737 - The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter